, Volume 3, Issue 12, pp 863-881
Date: 30 Aug 2012

Pharmacogenetic Tactics and Strategies

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


Genetic diversity exerts profound effects on variation in human drug response in adults, but comparatively little research that specifically relates to genetically abnormal responses in infancy and childhood has been reported. Specific genetic changes in human enzymes, receptors and other proteins that are implicated in drug response and their associated phenotypic correlates provide needed data for construction of profiles individualised to predict susceptibility to adverse drug reactions. If therapy adheres to such guidelines, failure to respond to drug therapy and drug toxicity among genetically susceptible persons can be greatly minimised or averted.